Search
Maybridge transitions to Thermo Scientific
Maybridge products are now branded Thermo Scientific
Effective October 2021, we are consolidating our chemicals portfolio, including Maybridge products, into one single brand, Thermo Scientific. These changes are being made to simplify our product and service offerings and provide our customers with one complete.
Accelerating drug discovery
At the cutting edge of innovative screening compound design for over 50 years, we seek to support the needs of drug discovery scientists and their pursuit of novel molecules of pharmaceutical interest.
We offer a comprehensive range of chemical products and services tailored to the pharmaceutical and biotechnology research sectors. Widely recognized for its market-leading diversity and quality, the Thermo Scientific collection of screening compounds was designed to help increase the success rate of your drug discovery research.
Screening compounds and libraries
At the forefront of our portfolio of screening compounds and libraries for hit identification are a highly diverse set of over 53,000 hit-like and lead-like molecules, and a fragment library which includes 30,000 chemical fragments, a tool designed to accelerate structure-based lead identification.
Featured products
A set of over 51,000 individually designed hit-like and lead-like molecules used in screening campaigns.
A collection of pharmacophorically rich intermediates specifically designed for medicinal chemistry research.
A library of over 30,000 chemical fragments designed to accelerate structure-based lead identification.
Featured webinar
High-Throughput Screening (HTS) and Fragment-Based Drug Discovery (FBDD)
Learn why early-phase drug discovery should not be like looking for a needle in a haystack!
Resources
Support
For Research Use Only. Not for use in diagnostic or therapeutic procedures.